254 related articles for article (PubMed ID: 34769292)
1. MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.
Yaron-Saminsky D; Nagaraj K; Sarfstein R; Laron Z; Pasmanik-Chor M; Werner H
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769292
[TBL] [Abstract][Full Text] [Related]
2. Identification of signaling pathways associated with cancer protection in Laron syndrome.
Lapkina-Gendler L; Rotem I; Pasmanik-Chor M; Gurwitz D; Sarfstein R; Laron Z; Werner H
Endocr Relat Cancer; 2016 May; 23(5):399-410. PubMed ID: 27090428
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors and aging: lessons from Laron syndrome.
Werner H; Laron Z
Front Endocrinol (Lausanne); 2023; 14():1291812. PubMed ID: 37941907
[TBL] [Abstract][Full Text] [Related]
4. The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
Shibel R; Sarfstein R; Nagaraj K; Lapkina-Gendler L; Laron Z; Dixit M; Yakar S; Werner H
Cells; 2021 Jun; 10(6):. PubMed ID: 34204736
[TBL] [Abstract][Full Text] [Related]
5. Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.
Sarfstein R; Nagaraj K; Parikh S; Levy C; Laron Z; Benayahu D; Werner H
Cells; 2022 May; 11(10):. PubMed ID: 35626664
[TBL] [Abstract][Full Text] [Related]
6. Identification of nephronectin as a new target for IGF1 action.
Sarfstein R; Lapkina-Gendler L; Nagaraj K; Laron Z; Werner H
Eur J Cancer; 2020 Dec; 141():115-127. PubMed ID: 33130549
[TBL] [Abstract][Full Text] [Related]
7. Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.
Nagaraj K; Lapkina-Gendler L; Sarfstein R; Gurwitz D; Pasmanik-Chor M; Laron Z; Yakar S; Werner H
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1045-1050. PubMed ID: 29339473
[TBL] [Abstract][Full Text] [Related]
8. Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.
Werner H; Sarfstein R; Nagaraj K; Laron Z
Cells; 2020 Nov; 9(11):. PubMed ID: 33182502
[TBL] [Abstract][Full Text] [Related]
9. Congenital IGF-1 deficiency protects from cancer: lessons from Laron syndrome.
Laron Z; Werner H
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37343154
[TBL] [Abstract][Full Text] [Related]
10. The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency.
Laron Z
Hormones (Athens); 2008; 7(1):24-7. PubMed ID: 18359741
[TBL] [Abstract][Full Text] [Related]
11. Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP.
Nagaraj K; Sarfstein R; Laron Z; Werner H
Cells; 2022 Oct; 11(20):. PubMed ID: 36291127
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.
Somri L; Sarfstein R; Lapkina-Gendler L; Nagaraj K; Laron Z; Bach LA; Werner H
Growth Horm IGF Res; 2018 Apr; 39():6-12. PubMed ID: 29208357
[TBL] [Abstract][Full Text] [Related]
13. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.
Laron Z; Kauli R; Lapkina L; Werner H
Mutat Res Rev Mutat Res; 2017; 772():123-133. PubMed ID: 28528685
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.
Werner H; Lapkina-Gendler L; Achlaug L; Nagaraj K; Somri L; Yaron-Saminsky D; Pasmanik-Chor M; Sarfstein R; Laron Z; Yakar S
Cells; 2019 Jun; 8(6):. PubMed ID: 31208077
[TBL] [Abstract][Full Text] [Related]
16. Association of lncRNA MEG3 rs941576 polymorphism, expression profile, and its related targets with the risk of obesity-related colorectal cancer: potential clinical insights.
Senousy MA; Shaker OG; Ayeldeen G; Radwan AF
Sci Rep; 2024 May; 14(1):10271. PubMed ID: 38704452
[TBL] [Abstract][Full Text] [Related]
17. LESSONS FROM 50 YEARS OF STUDY OF LARON SYNDROME.
Laron Z
Endocr Pract; 2015 Dec; 21(12):1395-402. PubMed ID: 26401581
[TBL] [Abstract][Full Text] [Related]
18. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.
Steuerman R; Shevah O; Laron Z
Eur J Endocrinol; 2011 Apr; 164(4):485-9. PubMed ID: 21292919
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
Guo ST; Jiang CC; Wang GP; Li YP; Wang CY; Guo XY; Yang RH; Feng Y; Wang FH; Tseng HY; Thorne RF; Jin L; Zhang XD
Oncogene; 2013 Apr; 32(15):1910-20. PubMed ID: 22710713
[TBL] [Abstract][Full Text] [Related]
20. Atypical defects resulting in growth hormone insensitivity.
Wit JM; de Luca F
Growth Horm IGF Res; 2016 Jun; 28():57-61. PubMed ID: 26670721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
